Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

JOURNAL ARTICLE published June 2019 in Annals of Oncology

Authors: Y. Fradet | J. Bellmunt | D.J. Vaughn | J.L. Lee | L. Fong | N.J. Vogelzang | M.A. Climent | D.P. Petrylak | T.K. Choueiri | A. Necchi | W. Gerritsen | H. Gurney | D.I. Quinn | S. Culine | C.N. Sternberg | K. Nam | T.L. Frenkl | R.F. Perini | R. de Wit | D.F. Bajorin